OXICODONA/NALOXONA SANDOZ 40mg / 20mg prolonged tablets medication leaflet

N02AA55 oxycodone + naloxone • Nervous system | Opioids | Natural opium alkaloids

The combination of oxycodone and naloxone is used for the treatment of severe pain requiring continuous opioid analgesic administration. Oxycodone is a potent opioid analgesic, while naloxone is an opioid antagonist that reduces the risk of opioid-induced constipation.

The medication is taken orally, usually as extended-release tablets, as directed by your doctor. It is important to follow the prescribed dosage to avoid the risk of dependence or other adverse effects.

Side effects may include nausea, drowsiness, dizziness, constipation, or, in rare cases, respiratory depression.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory or liver diseases, to ensure the safe use of this combination.

General data about OXICODONA/NALOXONA SANDOZ 40mg / 20mg

Substance: oxycodone + naloxone

Date of last drug list: 01-07-2021

Commercial code: W64205025

Concentration: 40mg / 20mg

Pharmaceutical form: prolonged tablets

Quantity: 84

Product type: generic

Prescription restrictions: PS - Medicines with special prescription (narcotics and psychotropic drugs).

Marketing authorisation

Manufacturer: SALUTAS PHARMA GMBH - GERMANIA

Holder: SANDOZ S.R.L. - ROMANIA

Number: 13622/2020/23

Shelf life: 3 years-after packing for marketing;after the first opening-3 months

Pharmaceutical forms available for oxycodone + naloxone

Concentrations available for oxycodone + naloxone

10mg/5mg, 15mg/7.5mg, 2.5mg/1.25mg, 20mg/10mg, 30mg/15mg, 40mg/20mg, 5mg/2.5mg, 60mg/30mg, 80mg/40mg

Other substances similar to oxycodone + naloxone